1.
J Clin Psychopharmacol
; 21(1): 119-20, 2001 Feb.
Article
in English
| MEDLINE
| ID: mdl-11199940
Subject(s)
Antipsychotic Agents/adverse effects , Antipsychotic Agents/economics , Pirenzepine/analogs & derivatives , Aged , Antipsychotic Agents/therapeutic use , Benzodiazepines , Depression/prevention & control , Drug Interactions , Female , Fluoxetine/adverse effects , Fluoxetine/economics , Fluoxetine/therapeutic use , Haloperidol/adverse effects , Haloperidol/economics , Haloperidol/therapeutic use , Health Care Costs , Humans , Olanzapine , Parkinson Disease/drug therapy , Pirenzepine/adverse effects , Pirenzepine/economics , Pirenzepine/therapeutic use , Selegiline/pharmacology , Selegiline/therapeutic use , Trihexyphenidyl/pharmacology , Trihexyphenidyl/therapeutic use
2.
J Clin Psychiatry
; 61(7): 526-7, 2000 Jul.
Article
in English
| MEDLINE
| ID: mdl-10937612
Subject(s)
Anticonvulsants/pharmacokinetics , Carbamazepine/pharmacokinetics , Depressive Disorder/drug therapy , Sertraline/therapeutic use , Adult , Anticonvulsants/therapeutic use , Carbamazepine/therapeutic use , Depressive Disorder/psychology , Drug Administration Schedule , Drug Interactions , Female , Humans , Male , Psychotic Disorders/drug therapy , Selective Serotonin Reuptake Inhibitors/blood , Selective Serotonin Reuptake Inhibitors/pharmacology , Selective Serotonin Reuptake Inhibitors/therapeutic use , Sertraline/blood , Sertraline/pharmacology , Stress Disorders, Post-Traumatic/drug therapy , Treatment Outcome
3.
J Clin Psychopharmacol
; 19(5): 471-2, 1999 Oct.
Article
in English
| MEDLINE
| ID: mdl-10505590
Subject(s)
Anticonvulsants/therapeutic use , Epilepsy, Tonic-Clonic/drug therapy , Fluoxetine/adverse effects , Phenytoin/therapeutic use , Selective Serotonin Reuptake Inhibitors/adverse effects , Substance Withdrawal Syndrome/psychology , Adult , Anticonvulsants/pharmacokinetics , Drug Interactions , Epilepsy, Tonic-Clonic/complications , Humans , Male , Phenytoin/pharmacokinetics
4.
J Clin Psychopharmacol
; 18(4): 346-7, 1998 Aug.
Article
in English
| MEDLINE
| ID: mdl-9690705
Subject(s)
Antipsychotic Agents/pharmacokinetics , Lithium Carbonate/pharmacokinetics , Neuroleptic Malignant Syndrome/blood , Paroxetine/pharmacokinetics , Perphenazine/pharmacokinetics , Selective Serotonin Reuptake Inhibitors/pharmacokinetics , Trazodone/pharmacokinetics , Antipsychotic Agents/administration & dosage , Antipsychotic Agents/adverse effects , Brain/drug effects , Drug Interactions , Drug Therapy, Combination , Humans , Lithium Carbonate/administration & dosage , Lithium Carbonate/adverse effects , Neuroleptic Malignant Syndrome/diagnosis , Paroxetine/administration & dosage , Paroxetine/adverse effects , Perphenazine/administration & dosage , Perphenazine/adverse effects , Selective Serotonin Reuptake Inhibitors/administration & dosage , Selective Serotonin Reuptake Inhibitors/adverse effects , Trazodone/administration & dosage , Trazodone/adverse effects
5.
J Clin Psychopharmacol
; 17(2): 118-9, 1997 Apr.
Article
in English
| MEDLINE
| ID: mdl-10950476
Subject(s)
Antidepressive Agents, Second-Generation/pharmacokinetics , Antidepressive Agents, Tricyclic/pharmacokinetics , Bupropion/pharmacokinetics , Imipramine/pharmacokinetics , Antidepressive Agents, Second-Generation/blood , Antidepressive Agents, Tricyclic/blood , Bupropion/blood , Cytochrome P-450 CYP2D6/metabolism , Drug Interactions , Female , Humans , Imipramine/blood , Middle Aged
6.
J Clin Psychiatry
; 58(12): 549-50, 1997 Dec.
Article
in English
| MEDLINE
| ID: mdl-9448661